Ecstasy use-Parkinson's disease link tenuous.
Jerome
Lisa
L
Doblin
Rick
R
Mithoefer
Michael
M
D000284:Administration, Oral; D018759:Adrenergic Uptake Inhibitors / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D006213:Hallucinogens / Q000633:toxicity*; D006801:Humans; D007279:Injections, Subcutaneous; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000633:toxicity*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D012306:Risk
D018759:Adrenergic Uptake Inhibitors; D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine